Literature DB >> 19486893

HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A.

Capucine Van Rechem1, Gaylor Boulay, Dominique Leprince.   

Abstract

HIC1, a tumor suppressor gene epigenetically silenced in many human cancers encodes a transcriptional repressor involved in regulatory loops modulating p53-dependent and E2F1-dependent cell survival and stress responses. HIC1 is also implicated in growth control since it recruits BRG1, one of the two alternative ATPases (BRM or BRG1) of SWI/SNF chromatin-remodeling complexes to repress transcription of E2F1 in quiescent fibroblasts. Here, through yeast two-hybrid screening, we identify ARID1A/BAF250A, as a new HIC1 partner. ARID1A/BAF250A is one of the two mutually exclusive ARID1-containing subunits of SWI/SNF complexes which define subsets of complexes endowed with anti-proliferative properties. Co-immunoprecipitation assays in WI38 fibroblasts and in BRG1-/- SW13 cells showed that endogenous HIC1 and ARID1A proteins interact in a BRG1-dependent manner. Furthermore, we demonstrate that HIC1 does not interact with BRM. Finally, sequential chromatin immunoprecipitation (ChIP-reChIP) experiments demonstrated that HIC1 represses E2F1 through the recruitment of anti-proliferative SWI/SNF complexes containing ARID1A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486893     DOI: 10.1016/j.bbrc.2009.05.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells.

Authors:  Capucine Van Rechem; Gaylor Boulay; Sébastien Pinte; Nicolas Stankovic-Valentin; Cateline Guérardel; Dominique Leprince
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

2.  Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.

Authors:  Gaylor Boulay; Marion Dubuissez; Capucine Van Rechem; Antoine Forget; Kristian Helin; Olivier Ayrault; Dominique Leprince
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 3.  DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

Authors:  Yutaka Hashimoto; Timothy J Zumwalt; Ajay Goel
Journal:  Epigenomics       Date:  2016-04-22       Impact factor: 4.778

4.  ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis.

Authors:  Yi Zhang; Xiaoman Xu; Meng Zhang; Xue Bai; Hui Li; Liang Kan; Huiyan Niu; Ping He
Journal:  Tumour Biol       Date:  2014-02-26

5.  Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma.

Authors:  Bin Guan; Tsui-Lien Mao; Pradeep K Panuganti; Elisabetta Kuhn; Robert J Kurman; Daichi Maeda; Elizabeth Chen; Yung-Ming Jeng; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

6.  Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis.

Authors:  G Wang; Y Fu; X Yang; X Luo; J Wang; J Gong; J Hu
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

7.  Loss of Hypermethylated in Cancer 1 (HIC1) in breast cancer cells contributes to stress-induced migration and invasion through β-2 adrenergic receptor (ADRB2) misregulation.

Authors:  Gaylor Boulay; Nicolas Malaquin; Ingrid Loison; Bénédicte Foveau; Capucine Van Rechem; Brian R Rood; Albin Pourtier; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

8.  ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.

Authors:  Bin Guan; Tian-Li Wang; Ie-Ming Shih
Journal:  Cancer Res       Date:  2011-09-07       Impact factor: 12.701

9.  The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review).

Authors:  Hiroshi Shigetomi; Akira Oonogi; Taihei Tsunemi; Yasuhito Tanase; Yoshihiko Yamada; Hirotaka Kajihara; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

10.  The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.

Authors:  Oluwole Fadare; Katja Gwin; Mohamed M Desouki; Marta A Crispens; Howard W Jones; Dineo Khabele; Sharon X Liang; Wenxin Zheng; Khaled Mohammed; Jonathan L Hecht; Vinita Parkash
Journal:  Mod Pathol       Date:  2013-03-22       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.